Takeda Pharmaceutical Co (Takeda Pharmaceutical Co) Total Equity

: $46,830 Mil (As of Dec. 2023)

View and export this data going back to 2010. Start your Free Trial

Takeda Pharmaceutical Co's total equity for the quarter that ended in Dec. 2023 was $46,830 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Takeda Pharmaceutical Co Total Equity Historical Data

The historical data trend for Takeda Pharmaceutical Co's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Takeda Pharmaceutical Co Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Total Equity

46,659.98

43,908.28

47,628.52

47,930.91

47,542.02

Takeda Pharmaceutical Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Equity																45,780.73	47,542.02	48,965.49	47,827.29	46,829.68

Takeda Pharmaceutical Co Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Takeda Pharmaceutical Co's Total Equity for the fiscal year that ended in Mar. 2023 is calculated as

Total Equity	=	Total Assets(Q: Mar. 2023 )	-	Total Liabilities(Q: Mar. 2023 )
	=	104423.919	-	56881.897
	=	47,542

Takeda Pharmaceutical Co's Total Equity for the quarter that ended in Dec. 2023 is calculated as

Total Equity	=	Total Assets(Q: Dec. 2023 )	-	Total Liabilities(Q: Dec. 2023 )
	=	98783.156	-	51953.48
	=	46,830

Takeda Pharmaceutical Co Total Equity Related Terms

Thank you for viewing the detailed overview of Takeda Pharmaceutical Co's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Takeda Pharmaceutical Co (Takeda Pharmaceutical Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Takeda Pharmaceutical Co Ltd (NYSE:TAK) » Definitions » Total Equity

Comparable Companies

Traded in Other Exchanges

TKPHF:USA TAK:Mexico 4502:Japan 4502:Japan 4502:Japan 4502:Japan TKDA:Germany TKD:Germany TKD:Germany TAKP34:Brazil

Address

1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, JPN, 103-8668

Website

https://www.takeda.com

Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4 trillion in fiscal 2022. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the U.S., 20% from Japan, 20% from Europe and Canada.